^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

PTCH1 mutation

i
Other names: PTC1, Patched Homolog 1, Protein Patched Homolog 1
Entrez ID:
Related biomarkers:
Phase 1
St. Jude Children's Research Hospital
Completed
Last update posted :
05/31/2024
Initiation :
03/05/2018
Primary completion :
09/30/2022
Completion :
05/24/2024
PTCH1
|
PTCH1 mutation
|
Mekinist (trametinib) • gemcitabine • Kisqali (ribociclib) • Odomzo (sonidegib) • Neupogen (filgrastim)
Phase 2
Alliance for Clinical Trials in Oncology
Recruiting
Last update posted :
05/23/2024
Initiation :
08/01/2015
Primary completion :
10/01/2024
Completion :
10/01/2024
PIK3CA • PTEN • CDKN2A • AKT1 • CCND1 • CCNE1 • PTCH1 • CDK4 • NF2 • SMO • CDK6 • CCND2 • CCND3
|
PIK3CA mutation • PTEN mutation • CDKN2A mutation • PTCH1 mutation • NF2 mutation • AKT1 mutation • SMO mutation • PIK3CA mutation + PTEN mutation • CDK4 mutation
|
Verzenio (abemaciclib) • Truqap (capivasertib) • Erivedge (vismodegib) • GSK2256098
Phase 1
Case Comprehensive Cancer Center
Active, not recruiting
Last update posted :
05/02/2024
Initiation :
10/01/2018
Primary completion :
09/01/2024
Completion :
09/01/2024
PTCH1
|
PTCH1 mutation
Phase 3
Sol-Gel Technologies, Ltd.
Recruiting
Last update posted :
04/19/2024
Initiation :
03/17/2024
Primary completion :
12/01/2025
Completion :
12/01/2025
PTCH1
|
PTCH1 mutation
|
patidegib topical (IPI-926 topical)
Phase 2
Endeavor Biomedicines, Inc.
Active, not recruiting
Last update posted :
12/18/2023
Initiation :
05/24/2022
Primary completion :
05/01/2024
Completion :
05/01/2024
PTCH1
|
PTCH1 mutation
|
taladegib (ENV 101)
Phase 3
PellePharm, Inc.
Completed
Last update posted :
03/08/2021
Initiation :
02/19/2019
Primary completion :
12/28/2020
Completion :
12/28/2020
PTCH1
|
PTCH1 mutation
|
patidegib topical (IPI-926 topical)
Phase 2
UCSF Benioff Children's Hospital Oakland
Completed
Last update posted :
10/29/2020
Initiation :
07/01/2004
Primary completion :
06/01/2012
Completion :
06/01/2012
PTCH1
|
PTCH1 mutation
Phase N/A
Edward Maytin, MD, PhD
Completed
Last update posted :
07/30/2020
Initiation :
02/01/2016
Primary completion :
09/01/2016
Completion :
12/01/2016
PTCH1
|
PTCH1 mutation
Phase 2
PellePharm, Inc.
Completed
Last update posted :
07/23/2020
Initiation :
06/06/2016
Primary completion :
04/24/2017
Completion :
04/24/2017
PTCH1 • GLI1
|
PTCH1 mutation
|
patidegib topical (IPI-926 topical)
Phase 2
Case Comprehensive Cancer Center
Active, not recruiting
Last update posted :
11/07/2016
Initiation :
12/01/2015
Primary completion :
10/01/2016
Completion :
12/01/2017
PTCH1
|
PTCH1 mutation
Phase 2
UCSF Benioff Children's Hospital Oakland
Completed
Last update posted :
02/11/2016
Initiation :
07/01/2004
Primary completion :
06/01/2012
Completion :
01/01/2014
PTCH1
|
PTCH1 mutation
Phase 2
Novartis Pharmaceuticals
Completed
Last update posted :
11/03/2015
Initiation :
07/01/2009
Primary completion :
08/01/2010
PTCH1
|
PTCH1 mutation
|
Odomzo (sonidegib)